Funding: Strep A/Rheumatic Heart Disease Vaccine Development
Global health & development
Funding
Global health & development
Funding
Routes to impact
Direct high impact on an important cause
Description
Funding for projects advancing Strep A vaccines and related work to reduce rheumatic heart disease.
- Phase 1 and controlled human infection model clinical trials
- Epidemiology, immunology, preclinical models, and in vitro assays
- Next-generation vaccine candidates, including new antigens and delivery optimization
- Regulatory, policy, and delivery preparation, including LMIC disease burden research
This text was generated by AI. If you notice any inconsistencies, please let us know using this form.



